Novast Holdings Ltd. is a FDA-inspected multinational pharmaceutical company with business units based in China and the United States. The company has a strong focus and proven record in the design and development of difficult formulations containing challenging Active Pharmaceutical Ingredients (APIs) for worldwide markets. Their strategy involves collaborating with pharmaceutical and biotechnology companies to develop and commercialise products for regulated markets.

Services include:
– Regulatory Services
– Containment
– Solid Dosage
– Packaging

In conclusion, Novast Holdings Ltd is committed to delivering high-quality solutions to the pharmaceutical industry. For more information, please visit novast.com.